SCG Cell Therapy to Present Groundbreaking Clinical Results for SCG142 at ESMO 2025 SCG Cell Therapy will unveil promising first-in-human results for SCG142 in HPV-related cancers at the 2025 ESMO Congress in Berlin. The findings signal hope for effective new treatments.

SCG Cell Therapy to Present Groundbreaking Clinical Results for SCG142 at ESMO 2025 #Singapore #Berlin #SCG_Cell_Therapy #HPV_cancer #SCG142

SCG Cell Therapy Unveils Promising Results for HPV-Related Cancer Treatment at ESMO 2025 SCG Cell Therapy presents first results of SCG142, showing strong efficacy in HPV-associated cancers. Learn more about this innovative T-cell therapy.

SCG Cell Therapy Unveils Promising Results for HPV-Related Cancer Treatment at ESMO 2025 #Singapore #Berlin #Immunotherapy #HPV_cancer #SCG142